Old Web
English
Sign In
Acemap
>
Paper
>
IMMU-05. A PHASE I STUDY IN PROGRESS OF HEGFRVIII-CD3 BI-SCFV (BRITE) IN PATIENTS WITH WHO GRADE IV MALIGNANT GLIOMA
IMMU-05. A PHASE I STUDY IN PROGRESS OF HEGFRVIII-CD3 BI-SCFV (BRITE) IN PATIENTS WITH WHO GRADE IV MALIGNANT GLIOMA
2021
Kirit Singh
Kelly Hotchkiss
Patrick C. Gedeon
Teilo Schaller
James E. Herndon
Gary E. Archer
John H. Sampson
Mustafa Khasraw
Keywords:
who grade
in patient
Glioma
Cancer research
phase i study
CD3
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]